VetMedGuide: Before Changing a Veterinary Analyzer Consumable SKU

When a distributor or secondary supplier offers a replacement cartridge, reagent rotor, CLIP, or similar analyzer consumable for an installed veterinary chemistry or hematology analyzer, purchasing has one job: compare the offered SKU to the installed analyzer as labeled identity, and record what manufacturer or laboratory review still has to decide. A look-alike panel name, a missing 510(k), or a human in-vitro diagnostic replacement-reagent policy is not permission to substitute.

Record, as separate fields, the installed platform and configuration, target species, sample type, consumable part number, lot, intended combination, IFU or insert revision, and storage evidence. Leave blank fields blank. Equivalence, calibration, species performance, and permission to use are not purchasing findings.

VetMedGuide is a publication, not a laboratory, regulator, analyzer manufacturer, or source of compatibility. Its in-house chemistry analyzer overview of platforms and consumable-cost structure compares installed-platform choices such as CLIP, rotor, and dry-slide formats. That page is related reading for how proprietary consumable families differ; it is not this SKU-substitution worksheet and is not an authority for duties, numeric performance, or compatibility.

This worksheet does not retell supplier quality agreements for consumable suppliers (purchasing-information, change-notice, and complaint-split fields under QMSR and ISO 13485). It also does not retell labeled storage and transport for medical consumables (labeled temperature, humidity, and distribution simulation as specifications). Storage appears here only as whether a labeled statement is present on the offer packet.

A missing 510(k) summary on an offered veterinary cartridge is not proof that the SKU is illicit, and it is not proof that the SKU is cleared, approved, or interchangeable. FDA's literacy page How FDA Regulates Animal Devices (content current as of 6 April 2026) states the actual split.

The Federal Food, Drug, and Cosmetic Act defines a medical device as an instrument, apparatus, implement, machine, contrivance, implant, in-vitro reagent, or other similar or related article, including any component, part, or accessory, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals. FDA has regulatory oversight over devices intended for animal use and can take action if an animal device is misbranded or adulterated.

The same page states that FDA does not require submission of a 510(k), PMA, or any premarket approval for devices intended for animal use. Device manufacturers who exclusively manufacture or distribute animal devices are not required to register their establishments or list those devices and are exempt from post-marketing reporting. It remains the manufacturer or distributor's responsibility to assure that animal devices are safe, effective, and properly labeled.

• No 510(k) or PMA: Absence of those submissions is the stated animal-device pathway. It is not an FDA animal-device approval and not a compatibility finding.

• Registration, listing, and post-marketing reporting: The exemption is stated for manufacturers who exclusively manufacture or distribute animal devices. It does not automatically describe dual human/animal product lines.

• Manufacturer labeling duty remains: Exemption from premarket submission does not remove misbranding and adulteration authority. Purchasing cannot invent interchangeability from the gap.

FDA's Importing Animal and Veterinary Products page (content current as of 16 July 2026) restates that exclusive animal-device manufacturers are not required to register or list veterinary devices and that, unlike devices intended for human use, PMA or 510(k) is not required for devices intended for animal use. FDA conducts label examinations of veterinary devices to ensure the labeling states that the device is for veterinary use only, and it points importers to CPG Sec. 607.100 for species-designation labeling. A veterinary-use-only statement is a labeling identity field. It is not a completed substitution decision and not proof that the offered SKU is the installed analyzer's intended combination.

The animal-devices page also states that FDA generally does not regulate the manner in which veterinarians use legally marketed devices in animals within the scope of their practice of veterinary medicine, while warning that off-label use is not permissible if it causes another FD&C Act violation and that, because FDA does not approve animal medical devices, device labeling may not be as well-developed as approved animal-drug labeling. A purchasing comparison of an offered SKU is therefore not a veterinarian's extra-label use decision.

Because FDA does not require premarket approval of animal devices, the offer packet's labeling is the purchaser's primary identity evidence. Species, sample matrix, and directions for use are specification fields, not optional brochure color.

Under FDA Compliance Policy Guide Sec. 607.100 (Adequate Directions for Use (Species Designation) — Animal Drugs and Veterinary Devices; issued 1 October 1980, revised March 1995; FDA HTML display marked content current as of 10 March 2015), veterinary-device labeling is in violation of FD&C Act section 502(f) if it fails to identify the target species or bear directions for use that are adequate for each target animal group for which it is intended. The guide's background states that effects and device use may vary across species and within a species by age, weight, size, and similar factors. CPG 607.100 is compliance policy, not a numeric performance table and not a finding that two SKUs are equivalent. A blank species field, a different target-animal group, or missing directions is not repaired by a matching catalog size.

Public manufacturer inserts show how tightly a labeled combination can be named. The VetScan Comprehensive Diagnostic Profile package insert (Abaxis/Zoetis, PN 500-7123 Rev. E, January 2015) is marked for veterinary use only. Its intended-use statement says the named reagent rotor used with the VetScan Chemistry Analyzer utilizes dry and liquid reagents to provide in vitro quantitative determinations in heparinized whole blood, heparinized plasma, or serum. The same insert states that the reagent rotor and the VetScan Chemistry Analyzer comprise an in vitro diagnostic system. Warnings include veterinary in-vitro diagnostic use and that a rotor with an opened diluent container cannot be reused. Those sentences are identity of that named system. They are not a brand ranking, not clearance of a substitute SKU, and not a calibration-constant table.

IDEXX Laboratories' Catalyst One Chemistry Analyzer operator's guide states that the Catalyst One analyzer is for veterinary use only. It treats named CLIPs and slides as the analyzer's test menu and lists supported sample types for those CLIPs and slides, including serum, lithium-heparin-treated plasma, and untreated whole blood with the named whole-blood separator for specified CLIPs. If an offer lists a different sample type, or lists none, that is a worksheet field—not a completed substitution decision.

Intended combination, part number, IFU or insert revision, sample type, and species or veterinary-use statement are therefore labeled identity fields. Purchasing cannot invent compatibility from a catalog look-alike, from the absence of a 510(k), or from a human IVD replacement-reagent policy.

Hospital buyers who also purchase for veterinary clinics sometimes reach for human-laboratory rules. Those rules do not authorize a veterinary cartridge substitute.

Under 42 CFR 493.1, Part 493 sets forth conditions that laboratories must meet to be certified to perform testing on human specimens under CLIA. Under 42 CFR 493.2, laboratory means a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings. eCFR displays are unofficial.

In CMS's 28 December 2023 CLIA final rule (CMS-3326-F), the agency stated that testing on human specimens is clearly specified in the statutory language and regulatory definition of a laboratory under CLIA. Therefore, testing of animal specimens does not meet the intent of the CLIA regulations. CDC's CLIA overview likewise describes federal standards applicable to U.S. facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. Those CLIA rules do not convert a veterinary in-clinic chemistry analyzer into a human clinical laboratory and do not supply a veterinary SKU-substitution rule.

A parallel boundary sits in Title 21. Part 809 is titled In Vitro Diagnostic Products for Human Use. 21 CFR 809.3 describes in vitro diagnostic products as reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae, and states that such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.

FDA's August 2022 guidance Replacement Reagent and Instrument Family Policy for In Vitro Diagnostic Devices is a human-IVD manufacturer 510(k) policy. It describes a mechanism for manufacturers to apply an assay previously cleared with a specified instrument to an additional instrument under predefined acceptance criteria, in some cases without a new 510(k). It is not a veterinary purchaser substitution worksheet, and it does not apply to animal-use devices that lack a 510(k) pathway. Citing it on a veterinary requisition does not create a federal substitution rule.

A USDA establishment or product license on one veterinary diagnostic class is not chemistry-rotor interchangeability. Purchasing still has to read which regime the labeled SKU actually sits under.

USDA APHIS's Veterinary Biologics page states that APHIS regulates veterinary biologics—vaccines, bacterins, antisera, diagnostic kits, and other products of biological origin—for the diagnosis, prevention, and treatment of animal diseases. That work is done by the Center for Veterinary Biologics and is centered on enforcement of the Virus-Serum-Toxin Act.

9 CFR 101.2 defines biological products as viruses, serums, toxins, or analogous products intended for use in the treatment of animals that act primarily through stimulation, supplementation, enhancement, or modulation of the immune system or immune response. The term includes diagnostic components of natural or synthetic origin. Analogous products include substances intended for use in the treatment of animals through the detection or measurement of antigens, antibodies, nucleic acids, or immunity. Treatment includes prevention, diagnosis, management, or cure of diseases of animals. eCFR is unofficial.

• USDA biologics class: Infectious-disease diagnostic kits of biological origin may sit here. A license on that class is identity of that kit, not a chemistry-panel substitute.

• FDA animal-device class: A chemistry or hematology cartridge or reagent rotor is not automatically the licensed-biologic class. The purchaser records which regime the labeled SKU claims, and leaves regime mismatches unknown rather than treating them as interchangeability.

Do not treat a USDA product license on a different kit class, a veterinary-use-only statement, or a matching panel name as proof that an offered chemistry SKU is the installed analyzer's intended combination.

The 2013 ASVCP guidelines on quality assurance for point-of-care testing in veterinary medicine, published in Veterinary Clinical Pathology (PubMed 24320778) and available as the May 2013 Version 1.0 PDF, recommend a formalized POCT approach, written procedures, operator training, assessment of instrument analytical performance, and use of non-expired, properly stored and handled reagents and quality-control materials. The same guideline notes that, unlike human POCT under CLIA, that federal oversight is not present in veterinary medicine. Those recommendations are professional consensus, not a substitution statute and not a legal duty invented for this worksheet.

• Non-expired, properly stored reagents and QCM: Recommended non-statistical QA includes use of non-expired, properly stored and handled reagents and quality-control materials. If reagents on the offer lack an expiry or a storage statement, record that absence.

• QCM compatibility information: Manufacturers of QCM should supply information regarding compatibility and use of their product with specific instruments, and manufacturer recommendations should be followed. That is a comparison input. It is not a finding that a substitute assay cartridge is equivalent.

• Lot and expiry on QCM: Commercially available QCM have a lot or batch number and an expiration date that must be observed.

• Training and written procedures: The guidelines treat documented training, competence, and written procedures as part of a formalized POCT approach. Purchasing can ask whether those documents name the offered SKU; it cannot certify analytical performance.

Manufacturer pages illustrate labeled operation of a named system. Zoetis's Vetscan VS2 chemistry analyzer support FAQ states that Vetscan VS2 reagents are factory calibrated and that the analyzer reads calibration values from the barcode on the rotor. It instructs users to store rotors in the labeled conditions and to use rotors directly from the refrigerator, and it directs rotor shelf life to the package label expiration date. It also states that the analyzer is specifically calibrated for different species and that if a rotor is run under the wrong species, the results may be inaccurate and a new rotor must be run under the correct species. Those sentences belong to that named system. They are not a third-party calibration constant, not a universal storage default, and not a recast of the published labeled-storage temperature article. On this worksheet, storage evidence is presence or absence of a labeled statement.

The original asset is the matrix below. Every row is hypothetical and fictional. The identifiers, lots, insert revisions, and brochure claims are internally consistent examples, not real products, not real lots, not clearances, and not permission to substitute. Do not treat any cell as a completed manufacturer or laboratory decision. A census of how replacement offers actually present these fields belongs on a later needs-data item and is not substituted here.

The VetMedGuide in-house chemistry analyzer buying overview remains platform and consumable-cost structure. This table is the offered-SKU identity packet that page does not write.

Each hypothetical row is an identity gap, not a pass or fail stamp:

• Offer A: A matching panel name does not replace a blank part number, blank lot, unnamed platform, or missing versioned insert.

• Offer B: A CLIP- or slide-format offer against an installed rotor platform is an intended-combination mismatch on the worksheet. Recording that mismatch is not a mechanical test and not permission to force-fit the SKU.

• Offer C: Even when a brochure names the chassis, incomplete target-animal-group directions under CPG 607.100 remain unknowns for manufacturer or laboratory review.

• Offer D: A fictional infectious-disease kit of biological origin offered against a chemistry rotor is a regime question. Purchasing records the class; it does not convert a biologics license into rotor interchangeability.

The flowchart below is a record-keeping path. It does not release a purchase order and does not authorize substitution.

flowchart TD
  A["Replacement consumable offer received"] --> B["Copy eight labeled identity fields"]
  B --> C{"Are platform, species, sample, part number, lot, intended combination, IFU revision, and storage evidence present and comparable as labeled?"}
  C -->|"Fields blank or mismatched as labeled"| D["Leave unknowns with manufacturer or laboratory review"]
  C -->|"Fields present"| E["Still not a substitution decision"]
  E --> F["Equivalence, calibration, and permission-to-use remain manufacturer or laboratory questions"]
  D --> F

Adjacent jobs stay on their own pages. Contract change-notice, complaint-split, and purchasing-information fields belong in quality agreements for consumable suppliers. Labeled temperature, humidity, and distribution evidence belong in labeled storage and transport for medical consumables. This page only asks whether an offered cartridge or reagent SKU is the installed labeled combination—and what still cannot be decided from the packet.